About vaxxinova
Vaxxinova is committed to provide and develop excellent technical products and services for food producing animals. We offer a wide range of licensed and autogenous vaccines. As well as a full set of diagnostic services. Our global R&D network focusses on improving our vaccines and services and develops new solutions.
Our commitments
In a fast-changing world, with continuing disease pressure and continuous risk of fast emerging diseases, Vaxxinova is committed to providing adequate preventive solutions. Microorganisms do not respect borders and can spread fast, both across geographical borders and across species. Vaxxinova believes in ‘business without borders’. In other words, we believe that long term local and global professional partnerships between Vaxxinova and veterinarians, animal health professionals and research institutes are the best way to prevent diseases, reduce the use of antibiotics and support performance improvement programs.
The development of vaccines is crucial for our society as vaccines support disease prevention. They make a positive contribution to ‘One Health’, the collaborative effort of multiple disciplines to attain optimal health for people, animals and the environment. Vaccines also help to make the food production more resource efficient and they support the antibiotics reduction.
Our history and background
Though Vaxxinova was officially named and founded in 2010, our predecessors have been in the production animal vaccine and diagnostics business since the 1950s. Vaxxinova can rely on more than 6 decades of expertise in disease prevention for production animals and our products and services are available in more than 75 countries.
Our current technology network comprises production, research & development and diagnostic facilities in 10 countries: Brazil, Chile, Italy, Germany, Japan, Jordan, Norway, Thailand, the USA and the Netherlands. Our location in the Netherlands also serves as our agile headquarters for the Vaxxinova Group.
We aim at providing a full range of both autogenous (where allowed) and licensed vaccines (where registered) combined with high-level diagnostic services, supported by our strong R&D. Our focus is on production animals including poultry, aqua, cattle and swine.
Vaxxinova is part of the family-owned EW Group which is based in Germany and specializes in the field of ‘Life Sciences’; genetics, diagnostics and healthcare sectors. The EW Group operates in over 100 countries and records consistent international growth. Its positive outlook and global orientation have led to an independent and significantly stable position in the market and a steady expansion.
As the EW Group is family-owned, which is rare in this sector these days, highly progressive strategies for the future can be pursued, based on long-term investment strategies.